Loading…

Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone promote antiviral immune response by activating NF-ĸB

Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone have been identified as tumor suppressors. However, their roles in virus infection remain unclear. Here, we demonstrate that PBLD upregulates the type I interferon (IFN-I) response through activating NF-kappaB (NF-κB) signali...

Full description

Saved in:
Bibliographic Details
Published in:Nature communications 2025-01, Vol.16 (1), p.496-18, Article 496
Main Authors: Hou, Peili, Zhu, Hongchao, Chu, Fengyun, Gao, Yan, Sun, Xiaonan, Zhang, Fuzhen, Wang, Xiaomeng, Feng, Yueyue, Li, Xingyu, Liu, Yu, Wang, Jun, Wang, Xiaoyun, He, Daniel Chang, Wang, Hongmei, He, Hongbin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c422t-59e011013b9c143147216ce586462d0cb12de8d9d4cf1b843bdadb840bad0bf3
container_end_page 18
container_issue 1
container_start_page 496
container_title Nature communications
container_volume 16
creator Hou, Peili
Zhu, Hongchao
Chu, Fengyun
Gao, Yan
Sun, Xiaonan
Zhang, Fuzhen
Wang, Xiaomeng
Feng, Yueyue
Li, Xingyu
Liu, Yu
Wang, Jun
Wang, Xiaoyun
He, Daniel Chang
Wang, Hongmei
He, Hongbin
description Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone have been identified as tumor suppressors. However, their roles in virus infection remain unclear. Here, we demonstrate that PBLD upregulates the type I interferon (IFN-I) response through activating NF-kappaB (NF-κB) signaling pathway to resist viral infection in cells and mice. Mechanistically, PBLD activates NF-κB signaling pathway during viral infection via blocking tripartite motif containing 21 (TRIM21)-mediated phosphorylated inhibitory kappa B kinase beta (IKKβ) degradation. Furthermore, we show Cedrelone inhibits viral replication by increasing the PBLD protein expression and subsequently activating NF-κB-mediated IFN-I response. Furthermore, the therapeutic potential of Cedrelone lies in its ability to enhance antiviral immunity in primary macrophages and to promote survival and reduce lung tissue damage in HSV-1-infected mice in a PBLD-dependent manner. Consequently, our findings provide a potential combination model that targets PBLD for Cedrelone antiviral drug therapy, potentially paving the way for the development of broad-spectrum antiviral agents. Phenazine biosynthesis-like domain-containing protein (PBLD) and cedrelone play roles in tumor suppression. Here, authors suggest that PBLD and Cedrelone inhibit viral replication via activating the NF-κB-mediated IFN-I signaling response in cells and mice.
doi_str_mv 10.1038/s41467-024-54882-y
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_3bfbd6c408b749bfa92e6e7f71512fb9</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_3bfbd6c408b749bfa92e6e7f71512fb9</doaj_id><sourcerecordid>3152797469</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-59e011013b9c143147216ce586462d0cb12de8d9d4cf1b843bdadb840bad0bf3</originalsourceid><addsrcrecordid>eNp9ks1uEzEUhUcIRKvSF2CBRmJTFgO-tjMerxANFCpF0EX3ln_uJC4zdrAnlcKOt-IBeDCcppSWBd5cy-f4873WqarnQF4DYd2bzIG3oiGUNzPedbTZPqoOKeHQgKDs8b39QXWc8xUpi0noOH9aHTAphGw7dlj9uFhh0N99wNr4mLdhWmH2uRn8V6xdHLUPjY1hKtWHZb1OcUIf6pOL08X7V7UOrp6jSzjEAijiWORyOvlrn_RQ-3HcFCFhXseQyxPbWtsi6mkH-3zW_Pp5-qx60ush4_FtPaouzz5czj81iy8fz-fvFo3llE7NTCIBIMCMtMAZcEGhtTjrWt5SR6wB6rBz0nHbg-k4M067UonRjpieHVXne6yL-kqtkx912qqovbo5iGmpdJq8HVAx0xvXWk46I7g0vZYUWxS9gBnQ3sjCertnrTdmRGcxTGXaB9CHSvArtYzXCkAAcMIK4eSWkOK3DeZJjT5bHAYdMG6yYtASSUkn2mJ9-Y_1Km5SKF9VXDMqpODtriW6d9kUc07Y33UDRO0Co_aBUSUw6iYwalsuvbg_x92VP_EoBrY35CKFJaa_b_8H-xudBc8c</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3152797469</pqid></control><display><type>article</type><title>Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone promote antiviral immune response by activating NF-ĸB</title><source>Nature</source><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><source>Coronavirus Research Database</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Hou, Peili ; Zhu, Hongchao ; Chu, Fengyun ; Gao, Yan ; Sun, Xiaonan ; Zhang, Fuzhen ; Wang, Xiaomeng ; Feng, Yueyue ; Li, Xingyu ; Liu, Yu ; Wang, Jun ; Wang, Xiaoyun ; He, Daniel Chang ; Wang, Hongmei ; He, Hongbin</creator><creatorcontrib>Hou, Peili ; Zhu, Hongchao ; Chu, Fengyun ; Gao, Yan ; Sun, Xiaonan ; Zhang, Fuzhen ; Wang, Xiaomeng ; Feng, Yueyue ; Li, Xingyu ; Liu, Yu ; Wang, Jun ; Wang, Xiaoyun ; He, Daniel Chang ; Wang, Hongmei ; He, Hongbin</creatorcontrib><description>Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone have been identified as tumor suppressors. However, their roles in virus infection remain unclear. Here, we demonstrate that PBLD upregulates the type I interferon (IFN-I) response through activating NF-kappaB (NF-κB) signaling pathway to resist viral infection in cells and mice. Mechanistically, PBLD activates NF-κB signaling pathway during viral infection via blocking tripartite motif containing 21 (TRIM21)-mediated phosphorylated inhibitory kappa B kinase beta (IKKβ) degradation. Furthermore, we show Cedrelone inhibits viral replication by increasing the PBLD protein expression and subsequently activating NF-κB-mediated IFN-I response. Furthermore, the therapeutic potential of Cedrelone lies in its ability to enhance antiviral immunity in primary macrophages and to promote survival and reduce lung tissue damage in HSV-1-infected mice in a PBLD-dependent manner. Consequently, our findings provide a potential combination model that targets PBLD for Cedrelone antiviral drug therapy, potentially paving the way for the development of broad-spectrum antiviral agents. Phenazine biosynthesis-like domain-containing protein (PBLD) and cedrelone play roles in tumor suppression. Here, authors suggest that PBLD and Cedrelone inhibit viral replication via activating the NF-κB-mediated IFN-I signaling response in cells and mice.</description><identifier>ISSN: 2041-1723</identifier><identifier>EISSN: 2041-1723</identifier><identifier>DOI: 10.1038/s41467-024-54882-y</identifier><identifier>PMID: 39779683</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>13/1 ; 13/109 ; 13/31 ; 13/95 ; 14/19 ; 38 ; 42 ; 45 ; 49 ; 59 ; 631/250/2504/342 ; 631/250/255/2514 ; 631/250/262 ; 631/326/596/2553 ; 64 ; 64/86 ; 96 ; Animals ; Antiviral agents ; Antiviral Agents - pharmacology ; Antiviral drugs ; Biosynthesis ; Cell survival ; Chemotherapy ; Cyclohexanones - pharmacology ; Drug therapy ; Female ; HEK293 Cells ; Herpes Simplex - drug therapy ; Herpes Simplex - immunology ; Herpes Simplex - virology ; Herpesvirus 1, Human - drug effects ; Herpesvirus 1, Human - immunology ; Humanities and Social Sciences ; Humans ; I-kappa B Kinase - metabolism ; Immune response ; Immune system ; Infections ; Interferon ; Interferon Type I - immunology ; Interferon Type I - metabolism ; Intracellular Signaling Peptides and Proteins ; Kinases ; Macrophages ; Macrophages - drug effects ; Macrophages - immunology ; Macrophages - metabolism ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; multidisciplinary ; NF-kappa B - metabolism ; NF-κB protein ; Phenazine ; Phenazines - pharmacology ; Protein biosynthesis ; Proteins ; Replication ; Science ; Science (multidisciplinary) ; Signal transduction ; Signal Transduction - drug effects ; Suppressors ; Tumor suppression ; Tumors ; Viral infections ; Virus Replication - drug effects</subject><ispartof>Nature communications, 2025-01, Vol.16 (1), p.496-18, Article 496</ispartof><rights>The Author(s) 2025</rights><rights>2025. The Author(s).</rights><rights>Copyright Nature Publishing Group 2025</rights><rights>The Author(s) 2025 2025</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c422t-59e011013b9c143147216ce586462d0cb12de8d9d4cf1b843bdadb840bad0bf3</cites><orcidid>0000-0002-7438-0638 ; 0009-0003-1629-1172</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3152797469/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3152797469?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,38493,43871,44566,53766,53768,74155,74869</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39779683$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hou, Peili</creatorcontrib><creatorcontrib>Zhu, Hongchao</creatorcontrib><creatorcontrib>Chu, Fengyun</creatorcontrib><creatorcontrib>Gao, Yan</creatorcontrib><creatorcontrib>Sun, Xiaonan</creatorcontrib><creatorcontrib>Zhang, Fuzhen</creatorcontrib><creatorcontrib>Wang, Xiaomeng</creatorcontrib><creatorcontrib>Feng, Yueyue</creatorcontrib><creatorcontrib>Li, Xingyu</creatorcontrib><creatorcontrib>Liu, Yu</creatorcontrib><creatorcontrib>Wang, Jun</creatorcontrib><creatorcontrib>Wang, Xiaoyun</creatorcontrib><creatorcontrib>He, Daniel Chang</creatorcontrib><creatorcontrib>Wang, Hongmei</creatorcontrib><creatorcontrib>He, Hongbin</creatorcontrib><title>Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone promote antiviral immune response by activating NF-ĸB</title><title>Nature communications</title><addtitle>Nat Commun</addtitle><addtitle>Nat Commun</addtitle><description>Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone have been identified as tumor suppressors. However, their roles in virus infection remain unclear. Here, we demonstrate that PBLD upregulates the type I interferon (IFN-I) response through activating NF-kappaB (NF-κB) signaling pathway to resist viral infection in cells and mice. Mechanistically, PBLD activates NF-κB signaling pathway during viral infection via blocking tripartite motif containing 21 (TRIM21)-mediated phosphorylated inhibitory kappa B kinase beta (IKKβ) degradation. Furthermore, we show Cedrelone inhibits viral replication by increasing the PBLD protein expression and subsequently activating NF-κB-mediated IFN-I response. Furthermore, the therapeutic potential of Cedrelone lies in its ability to enhance antiviral immunity in primary macrophages and to promote survival and reduce lung tissue damage in HSV-1-infected mice in a PBLD-dependent manner. Consequently, our findings provide a potential combination model that targets PBLD for Cedrelone antiviral drug therapy, potentially paving the way for the development of broad-spectrum antiviral agents. Phenazine biosynthesis-like domain-containing protein (PBLD) and cedrelone play roles in tumor suppression. Here, authors suggest that PBLD and Cedrelone inhibit viral replication via activating the NF-κB-mediated IFN-I signaling response in cells and mice.</description><subject>13/1</subject><subject>13/109</subject><subject>13/31</subject><subject>13/95</subject><subject>14/19</subject><subject>38</subject><subject>42</subject><subject>45</subject><subject>49</subject><subject>59</subject><subject>631/250/2504/342</subject><subject>631/250/255/2514</subject><subject>631/250/262</subject><subject>631/326/596/2553</subject><subject>64</subject><subject>64/86</subject><subject>96</subject><subject>Animals</subject><subject>Antiviral agents</subject><subject>Antiviral Agents - pharmacology</subject><subject>Antiviral drugs</subject><subject>Biosynthesis</subject><subject>Cell survival</subject><subject>Chemotherapy</subject><subject>Cyclohexanones - pharmacology</subject><subject>Drug therapy</subject><subject>Female</subject><subject>HEK293 Cells</subject><subject>Herpes Simplex - drug therapy</subject><subject>Herpes Simplex - immunology</subject><subject>Herpes Simplex - virology</subject><subject>Herpesvirus 1, Human - drug effects</subject><subject>Herpesvirus 1, Human - immunology</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>I-kappa B Kinase - metabolism</subject><subject>Immune response</subject><subject>Immune system</subject><subject>Infections</subject><subject>Interferon</subject><subject>Interferon Type I - immunology</subject><subject>Interferon Type I - metabolism</subject><subject>Intracellular Signaling Peptides and Proteins</subject><subject>Kinases</subject><subject>Macrophages</subject><subject>Macrophages - drug effects</subject><subject>Macrophages - immunology</subject><subject>Macrophages - metabolism</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>multidisciplinary</subject><subject>NF-kappa B - metabolism</subject><subject>NF-κB protein</subject><subject>Phenazine</subject><subject>Phenazines - pharmacology</subject><subject>Protein biosynthesis</subject><subject>Proteins</subject><subject>Replication</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Signal transduction</subject><subject>Signal Transduction - drug effects</subject><subject>Suppressors</subject><subject>Tumor suppression</subject><subject>Tumors</subject><subject>Viral infections</subject><subject>Virus Replication - drug effects</subject><issn>2041-1723</issn><issn>2041-1723</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9ks1uEzEUhUcIRKvSF2CBRmJTFgO-tjMerxANFCpF0EX3ln_uJC4zdrAnlcKOt-IBeDCcppSWBd5cy-f4873WqarnQF4DYd2bzIG3oiGUNzPedbTZPqoOKeHQgKDs8b39QXWc8xUpi0noOH9aHTAphGw7dlj9uFhh0N99wNr4mLdhWmH2uRn8V6xdHLUPjY1hKtWHZb1OcUIf6pOL08X7V7UOrp6jSzjEAijiWORyOvlrn_RQ-3HcFCFhXseQyxPbWtsi6mkH-3zW_Pp5-qx60ush4_FtPaouzz5czj81iy8fz-fvFo3llE7NTCIBIMCMtMAZcEGhtTjrWt5SR6wB6rBz0nHbg-k4M067UonRjpieHVXne6yL-kqtkx912qqovbo5iGmpdJq8HVAx0xvXWk46I7g0vZYUWxS9gBnQ3sjCertnrTdmRGcxTGXaB9CHSvArtYzXCkAAcMIK4eSWkOK3DeZJjT5bHAYdMG6yYtASSUkn2mJ9-Y_1Km5SKF9VXDMqpODtriW6d9kUc07Y33UDRO0Co_aBUSUw6iYwalsuvbg_x92VP_EoBrY35CKFJaa_b_8H-xudBc8c</recordid><startdate>20250108</startdate><enddate>20250108</enddate><creator>Hou, Peili</creator><creator>Zhu, Hongchao</creator><creator>Chu, Fengyun</creator><creator>Gao, Yan</creator><creator>Sun, Xiaonan</creator><creator>Zhang, Fuzhen</creator><creator>Wang, Xiaomeng</creator><creator>Feng, Yueyue</creator><creator>Li, Xingyu</creator><creator>Liu, Yu</creator><creator>Wang, Jun</creator><creator>Wang, Xiaoyun</creator><creator>He, Daniel Chang</creator><creator>Wang, Hongmei</creator><creator>He, Hongbin</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><general>Nature Portfolio</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SN</scope><scope>7SS</scope><scope>7ST</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>SOI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-7438-0638</orcidid><orcidid>https://orcid.org/0009-0003-1629-1172</orcidid></search><sort><creationdate>20250108</creationdate><title>Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone promote antiviral immune response by activating NF-ĸB</title><author>Hou, Peili ; Zhu, Hongchao ; Chu, Fengyun ; Gao, Yan ; Sun, Xiaonan ; Zhang, Fuzhen ; Wang, Xiaomeng ; Feng, Yueyue ; Li, Xingyu ; Liu, Yu ; Wang, Jun ; Wang, Xiaoyun ; He, Daniel Chang ; Wang, Hongmei ; He, Hongbin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-59e011013b9c143147216ce586462d0cb12de8d9d4cf1b843bdadb840bad0bf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>13/1</topic><topic>13/109</topic><topic>13/31</topic><topic>13/95</topic><topic>14/19</topic><topic>38</topic><topic>42</topic><topic>45</topic><topic>49</topic><topic>59</topic><topic>631/250/2504/342</topic><topic>631/250/255/2514</topic><topic>631/250/262</topic><topic>631/326/596/2553</topic><topic>64</topic><topic>64/86</topic><topic>96</topic><topic>Animals</topic><topic>Antiviral agents</topic><topic>Antiviral Agents - pharmacology</topic><topic>Antiviral drugs</topic><topic>Biosynthesis</topic><topic>Cell survival</topic><topic>Chemotherapy</topic><topic>Cyclohexanones - pharmacology</topic><topic>Drug therapy</topic><topic>Female</topic><topic>HEK293 Cells</topic><topic>Herpes Simplex - drug therapy</topic><topic>Herpes Simplex - immunology</topic><topic>Herpes Simplex - virology</topic><topic>Herpesvirus 1, Human - drug effects</topic><topic>Herpesvirus 1, Human - immunology</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>I-kappa B Kinase - metabolism</topic><topic>Immune response</topic><topic>Immune system</topic><topic>Infections</topic><topic>Interferon</topic><topic>Interferon Type I - immunology</topic><topic>Interferon Type I - metabolism</topic><topic>Intracellular Signaling Peptides and Proteins</topic><topic>Kinases</topic><topic>Macrophages</topic><topic>Macrophages - drug effects</topic><topic>Macrophages - immunology</topic><topic>Macrophages - metabolism</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>multidisciplinary</topic><topic>NF-kappa B - metabolism</topic><topic>NF-κB protein</topic><topic>Phenazine</topic><topic>Phenazines - pharmacology</topic><topic>Protein biosynthesis</topic><topic>Proteins</topic><topic>Replication</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Signal transduction</topic><topic>Signal Transduction - drug effects</topic><topic>Suppressors</topic><topic>Tumor suppression</topic><topic>Tumors</topic><topic>Viral infections</topic><topic>Virus Replication - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hou, Peili</creatorcontrib><creatorcontrib>Zhu, Hongchao</creatorcontrib><creatorcontrib>Chu, Fengyun</creatorcontrib><creatorcontrib>Gao, Yan</creatorcontrib><creatorcontrib>Sun, Xiaonan</creatorcontrib><creatorcontrib>Zhang, Fuzhen</creatorcontrib><creatorcontrib>Wang, Xiaomeng</creatorcontrib><creatorcontrib>Feng, Yueyue</creatorcontrib><creatorcontrib>Li, Xingyu</creatorcontrib><creatorcontrib>Liu, Yu</creatorcontrib><creatorcontrib>Wang, Jun</creatorcontrib><creatorcontrib>Wang, Xiaoyun</creatorcontrib><creatorcontrib>He, Daniel Chang</creatorcontrib><creatorcontrib>Wang, Hongmei</creatorcontrib><creatorcontrib>He, Hongbin</creatorcontrib><collection>SpringerOpen</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Environment Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biological Science Database</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>Environment Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Nature communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hou, Peili</au><au>Zhu, Hongchao</au><au>Chu, Fengyun</au><au>Gao, Yan</au><au>Sun, Xiaonan</au><au>Zhang, Fuzhen</au><au>Wang, Xiaomeng</au><au>Feng, Yueyue</au><au>Li, Xingyu</au><au>Liu, Yu</au><au>Wang, Jun</au><au>Wang, Xiaoyun</au><au>He, Daniel Chang</au><au>Wang, Hongmei</au><au>He, Hongbin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone promote antiviral immune response by activating NF-ĸB</atitle><jtitle>Nature communications</jtitle><stitle>Nat Commun</stitle><addtitle>Nat Commun</addtitle><date>2025-01-08</date><risdate>2025</risdate><volume>16</volume><issue>1</issue><spage>496</spage><epage>18</epage><pages>496-18</pages><artnum>496</artnum><issn>2041-1723</issn><eissn>2041-1723</eissn><abstract>Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone have been identified as tumor suppressors. However, their roles in virus infection remain unclear. Here, we demonstrate that PBLD upregulates the type I interferon (IFN-I) response through activating NF-kappaB (NF-κB) signaling pathway to resist viral infection in cells and mice. Mechanistically, PBLD activates NF-κB signaling pathway during viral infection via blocking tripartite motif containing 21 (TRIM21)-mediated phosphorylated inhibitory kappa B kinase beta (IKKβ) degradation. Furthermore, we show Cedrelone inhibits viral replication by increasing the PBLD protein expression and subsequently activating NF-κB-mediated IFN-I response. Furthermore, the therapeutic potential of Cedrelone lies in its ability to enhance antiviral immunity in primary macrophages and to promote survival and reduce lung tissue damage in HSV-1-infected mice in a PBLD-dependent manner. Consequently, our findings provide a potential combination model that targets PBLD for Cedrelone antiviral drug therapy, potentially paving the way for the development of broad-spectrum antiviral agents. Phenazine biosynthesis-like domain-containing protein (PBLD) and cedrelone play roles in tumor suppression. Here, authors suggest that PBLD and Cedrelone inhibit viral replication via activating the NF-κB-mediated IFN-I signaling response in cells and mice.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>39779683</pmid><doi>10.1038/s41467-024-54882-y</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0002-7438-0638</orcidid><orcidid>https://orcid.org/0009-0003-1629-1172</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2041-1723
ispartof Nature communications, 2025-01, Vol.16 (1), p.496-18, Article 496
issn 2041-1723
2041-1723
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_3bfbd6c408b749bfa92e6e7f71512fb9
source Nature; Publicly Available Content (ProQuest); PubMed Central; Coronavirus Research Database; Springer Nature - nature.com Journals - Fully Open Access
subjects 13/1
13/109
13/31
13/95
14/19
38
42
45
49
59
631/250/2504/342
631/250/255/2514
631/250/262
631/326/596/2553
64
64/86
96
Animals
Antiviral agents
Antiviral Agents - pharmacology
Antiviral drugs
Biosynthesis
Cell survival
Chemotherapy
Cyclohexanones - pharmacology
Drug therapy
Female
HEK293 Cells
Herpes Simplex - drug therapy
Herpes Simplex - immunology
Herpes Simplex - virology
Herpesvirus 1, Human - drug effects
Herpesvirus 1, Human - immunology
Humanities and Social Sciences
Humans
I-kappa B Kinase - metabolism
Immune response
Immune system
Infections
Interferon
Interferon Type I - immunology
Interferon Type I - metabolism
Intracellular Signaling Peptides and Proteins
Kinases
Macrophages
Macrophages - drug effects
Macrophages - immunology
Macrophages - metabolism
Mice
Mice, Inbred C57BL
Mice, Knockout
multidisciplinary
NF-kappa B - metabolism
NF-κB protein
Phenazine
Phenazines - pharmacology
Protein biosynthesis
Proteins
Replication
Science
Science (multidisciplinary)
Signal transduction
Signal Transduction - drug effects
Suppressors
Tumor suppression
Tumors
Viral infections
Virus Replication - drug effects
title Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone promote antiviral immune response by activating NF-ĸB
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T23%3A54%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phenazine%20biosynthesis-like%20domain-containing%20protein%20(PBLD)%20and%20Cedrelone%20promote%20antiviral%20immune%20response%20by%20activating%20NF-%C4%B8B&rft.jtitle=Nature%20communications&rft.au=Hou,%20Peili&rft.date=2025-01-08&rft.volume=16&rft.issue=1&rft.spage=496&rft.epage=18&rft.pages=496-18&rft.artnum=496&rft.issn=2041-1723&rft.eissn=2041-1723&rft_id=info:doi/10.1038/s41467-024-54882-y&rft_dat=%3Cproquest_doaj_%3E3152797469%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c422t-59e011013b9c143147216ce586462d0cb12de8d9d4cf1b843bdadb840bad0bf3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3152797469&rft_id=info:pmid/39779683&rfr_iscdi=true